CA2590537C - Utilisation de la composante neurotoxique de la toxine botulinique pour le traitement du larmoiement excessif - Google Patents

Utilisation de la composante neurotoxique de la toxine botulinique pour le traitement du larmoiement excessif Download PDF

Info

Publication number
CA2590537C
CA2590537C CA002590537A CA2590537A CA2590537C CA 2590537 C CA2590537 C CA 2590537C CA 002590537 A CA002590537 A CA 002590537A CA 2590537 A CA2590537 A CA 2590537A CA 2590537 C CA2590537 C CA 2590537C
Authority
CA
Canada
Prior art keywords
botulinum toxin
units
botulinum
treatment
injected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002590537A
Other languages
English (en)
Other versions
CA2590537A1 (fr
Inventor
Michael W. Grayston
Steven R. Carlson
K. Roger Aoki
Judith M. Leon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority claimed from CA002300766A external-priority patent/CA2300766C/fr
Publication of CA2590537A1 publication Critical patent/CA2590537A1/fr
Application granted granted Critical
Publication of CA2590537C publication Critical patent/CA2590537C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002590537A 1993-12-28 1994-12-16 Utilisation de la composante neurotoxique de la toxine botulinique pour le traitement du larmoiement excessif Expired - Lifetime CA2590537C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17399693A 1993-12-28 1993-12-28
US08/173,996 1993-12-28
CA002300766A CA2300766C (fr) 1993-12-28 1994-12-16 Methode pour traiter une secretion cholinergique influencee

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002300766A Division CA2300766C (fr) 1993-12-28 1994-12-16 Methode pour traiter une secretion cholinergique influencee

Publications (2)

Publication Number Publication Date
CA2590537A1 CA2590537A1 (fr) 1995-07-06
CA2590537C true CA2590537C (fr) 2009-10-13

Family

ID=38236376

Family Applications (6)

Application Number Title Priority Date Filing Date
CA002589989A Expired - Lifetime CA2589989C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique de la toxine botulinique pour traiter la sudation excessive
CA002589968A Abandoned CA2589968A1 (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique de la toxine botulinique pour traiter des douleurs associees a l'activite ou la contracture musculaire
CA002590293A Expired - Lifetime CA2590293C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique du botulinum pour le traitement d'un muscle spastique
CA002590540A Expired - Lifetime CA2590540C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique d'une toxine botulinique pour le traitement de secretions muqueuses excessives
CA002590537A Expired - Lifetime CA2590537C (fr) 1993-12-28 1994-12-16 Utilisation de la composante neurotoxique de la toxine botulinique pour le traitement du larmoiement excessif
CA002589987A Expired - Fee Related CA2589987C (fr) 1993-12-28 1994-12-16 Methode pour traiter une secretion cholinergique influencee

Family Applications Before (4)

Application Number Title Priority Date Filing Date
CA002589989A Expired - Lifetime CA2589989C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique de la toxine botulinique pour traiter la sudation excessive
CA002589968A Abandoned CA2589968A1 (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique de la toxine botulinique pour traiter des douleurs associees a l'activite ou la contracture musculaire
CA002590293A Expired - Lifetime CA2590293C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique du botulinum pour le traitement d'un muscle spastique
CA002590540A Expired - Lifetime CA2590540C (fr) 1993-12-28 1994-12-16 Utilisation du composant neurotoxique d'une toxine botulinique pour le traitement de secretions muqueuses excessives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002589987A Expired - Fee Related CA2589987C (fr) 1993-12-28 1994-12-16 Methode pour traiter une secretion cholinergique influencee

Country Status (1)

Country Link
CA (6) CA2589989C (fr)

Also Published As

Publication number Publication date
CA2590537A1 (fr) 1995-07-06
CA2589987A1 (fr) 1995-07-06
CA2589968A1 (fr) 1995-07-06
CA2589989A1 (fr) 1995-07-06
CA2590540C (fr) 2009-05-05
CA2590293C (fr) 2009-05-12
CA2589989C (fr) 2009-05-12
CA2589987C (fr) 2008-05-20
CA2590540A1 (fr) 1995-07-06
CA2590293A1 (fr) 1995-07-06

Similar Documents

Publication Publication Date Title
AU688452B2 (en) Botulinum toxins for treating various disorders and associated pain
US8216995B2 (en) Botulinum toxin treatments
US20040151740A1 (en) Botulinum toxin treatment for blepharospasm
US8557256B2 (en) Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
CA2590537C (fr) Utilisation de la composante neurotoxique de la toxine botulinique pour le traitement du larmoiement excessif
CA2300663C (fr) Methode pour traiter la dyphagie

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141216